Advisory - Multiple lots of irbesartan, losartan and valsartan drugs recalled
OTTAWA, ON, Oct. 1, 2021 /CNW/ -
Summary
- Products: Irbesartan, losartan and valsartan drugs
- Issue: Several companies are recalling multiple lots of these products due to the presence of an azido impurity
- What to do: Continue taking your medication unless you have been advised to stop by your healthcare provider. Not treating your condition may pose a greater health risk.
Issue
UPDATE (October 1, 2021): Auro Pharma Inc. recalls certain lots of losartan due to azido impurity
Auro Pharma Inc. is recalling seven lots of prescription losartan tablets, in 25 mg, 50 mg and 100 mg strengths, after tests found an azido impurity (5-(4'-((5-(azidomethyl)-2-butyl-4-chloro-1H imidazol-1-yl)methyl)-[1,1'-biphenyl]-2-yl)-1H tetrazole) above the acceptable limit. Long-term exposure to this impurity at levels above what is considered safe could potentially increase the risk of cancer.
Refer to the Affected Products table below for information on the recalled lots, and to the section below on what you should do. Health Canada's assessment of the presence of this second azido impurity in losartan products in Canada is ongoing. Health Canada has requested that companies marketing losartan in Canada perform detailed evaluations of their manufacturing processes and controls and to conduct testing as necessary. Should additional recalls be necessary, the Department will update the list of affected products and inform Canadians.
UPDATE (September 16, 2021): Sandoz Canada Inc. and Sanis Health Inc. recall multiple lots of losartan due to azido impurity
Sandoz Canada Inc. and Sanis Health Inc. are recalling all lots of prescription losartan tablets, in
25 mg, 50 mg and 100 mg strengths, after tests found an azido impurity (5-(4'-((5-(azidomethyl)-2-butyl-4-chloro-1H imidazol-1-yl)methyl)-[1,1'-biphenyl]-2-yl)-1H tetrazole) above the acceptable limit. Long-term exposure to this impurity at levels above what is considered safe could potentially increase the risk of cancer.
Refer to the Affected Products table below for information on the recalled lots, and to the section below on what you should do. Health Canada's assessment of the issue regarding presence of this second azido impurity in losartan products in Canada is ongoing. Should additional recalls be necessary, the Department will update the list of affected products and inform Canadians.
UPDATE (August 28, 2021): Certain lots of Teva-Losartan and Sivem-Losartan recalled due to azido impurity
Teva Canada Ltd. and Sivem Pharmaceuticals ULC are recalling a total of seven lots of prescription losartan tablets, in 25mg, 50mg and 100 mg strengths, after tests found an azido impurity (5-(4'-((5-(azidomethyl)-2-butyl-4-chloro-1H imidazol-1-yl)methyl)-[1,1'-biphenyl]-2-yl)-1H tetrazole) above the acceptable limit.
As with the different azido impurity that Health Canada communicated about on May 30, 2021 (see below), long-term exposure to levels above what is considered safe could potentially increase the risk of cancer.
Refer to the Affected Products table below for information on the recalled lots, and to the section below on what you should do. Should additional recalls be necessary, Health Canada will update the list of affected products and inform Canadians.
UPDATE (June 15, 2021): sanofi-aventis Canada Inc. recalls 12 lots of irbesartan drugs due to azido impurity
sanofi-aventis Canada Inc. is recalling 12 lots of prescription irbesartan tablets (brand names Avalide and Avapro, in various strengths) after tests found the azido impurity above the acceptable limit. Refer to the Affected Products table below for detailed information on the recalled lots.
Should additional recalls be necessary, Health Canada will update the list of affected products and inform Canadians.
Original Advisory (May 30, 2021): Multiple lots of irbesartan, losartan and valsartan drugs recalled due to azido impurity
Health Canada is informing Canadians that several companies are recalling multiple lots of irbesartan, losartan and valsartan drug products after tests found an azido impurity above the acceptable limit (see list of affected products below).
Irbesartan, losartan and valsartan are all prescription angiotensin receptor blocker (ARB) drugs, which are also known as "sartans." Sartans are a class of drugs used to treat patients with high blood pressure to help prevent heart attacks and stroke. They are also used in patients with heart failure or those who have had a recent heart attack.
The azido impurity, 5-(4'-(azidomethyl)-[1,1'-biphenyl]-2yl)-1H-tetrazole, is considered a mutagen. A mutagen is a chemical substance that can cause a change in the DNA of a cell. These mutations may increase the risk of cancer but the specific risk for this azido impurity to cause cancer in humans is unknown.
There are established international guidelines that recommend that mutagenic impurities be kept at or below a specific level because exposure to a mutagen over the long term at a level above what is considered to be safe, has the potential to increase the risk of cancer. A person taking a drug daily for 70 years that contains this azido impurity at or below the acceptable level is not expected to have an increased risk of cancer.
Not all lots of irbesartan, losartan and valsartan from these companies are affected by this issue; however, it is possible that the recalls may affect the supply of some products. Patients should speak with their doctor or pharmacist to discuss alternatives should their regular prescribed drug not be available.
The Department expects manufacturers to take any necessary actions to reduce or eliminate the azido impurity. Impacted companies have been directed to implement control measures to ensure that the level of the impurity in their products are at or below the acceptable level. Health Canada is monitoring the effectiveness of the recalls. Should additional recalls be deemed necessary, Health Canada will inform Canadians.
What you should do
- Continue taking your medication unless you have been advised to stop by your healthcare provider. There is no immediate risk to patients taking these medications, since the potential increased risk of cancer is with long-term exposure to the impurity. Not treating your condition may pose a greater health risk.
- If you have been using an affected product, contact your healthcare provider as soon as possible to discuss treatment options. Pharmacists may be able to provide a product not affected by the recall, or your doctor may prescribe a different medication for your condition.
- Report any health product side effects or complaints to Health Canada.
- Contact the company directly if you have questions about a recall:
- Auro Pharma Inc. by calling toll free at 1-855-568-2511, or by email at cs@auropharma.ca
- Mint Pharmaceuticals Inc. by calling 1-905-795-9437, extension 2201, or by email at orders@mintpharmaceuticals.com
- Pharmascience Inc. by calling toll free at 1-800-340-9735
- Pro Doc Ltd. by calling toll free at 1-800-361-8559
- sanofi-aventis Canada Inc. by calling toll free at 1–800-265-7927
- Sandoz Canada Inc. by calling toll free at 1-800-343-8839
- Sanis Health Inc. by calling toll free at 1-866-236-4076, or by email at quality@sanis.com
- Sivem Pharmaceuticals ULC by calling toll free at 1-855-757-4836
- Sun Pharma Canada Inc. by calling toll free at 1-800-268-1975, or by email at customerservice@taro.ca
- Teva Canada Ltd. by calling toll free at 1-800-268-4129
Affected products
Products are listed alphabetically by name.
|
Product |
Company |
DIN |
Lot |
Expiry |
Date Added |
|
Irbesartan |
|||||
|
AVALIDE 150-12.5 mg TABLETS |
sanofi-aventis Canada |
02241818 |
ET02879 |
June 2021 |
June 15, 2021 |
|
AVALIDE 150-12.5 mg TABLETS |
sanofi-aventis Canada |
02241818 |
FT01327 |
December 2021 |
June 15, 2021 |
|
AVALIDE 300-12.5 mg TABLETS |
sanofi-aventis Canada |
02241819 |
FT01644 |
February 2022 |
June 15, 2021 |
|
AVAPRO 75 mg TABLETS |
sanofi-aventis Canada |
02237923 |
FT00590 |
October 2021 |
June 15, 2021 |
|
AVAPRO 150 mg TABLETS |
sanofi-aventis Canada |
02237924 |
FT01238 |
January 2022 |
June 15, 2021 |
|
AVAPRO 150 mg TABLETS |
sanofi-aventis Canada |
02237924 |
ET04153 |
August 2021 |
June 15, 2021 |
|
AVAPRO 150 mg TABLETS |
sanofi-aventis Canada |
02237924 |
FT01995 |
March 2022 |
June 15, 2021 |
|
AVAPRO 300 mg TABLETS |
sanofi-aventis Canada |
02237925 |
FT00969 |
January 2022 |
June 15, 2021 |
|
AVAPRO 300 mg TABLETS |
sanofi-aventis Canada |
02237925 |
FT01225 |
January 2022 |
June 15, 2021 |
|
AVAPRO 300 mg TABLETS |
sanofi-aventis Canada |
02237925 |
FT01226 |
January 2022 |
June 15, 2021 |
|
AVAPRO 300 mg TABLETS |
sanofi-aventis Canada |
02237925 |
FT01999 |
March 2022 |
June 15, 2021 |
|
AVAPRO 300 mg TABLETS |
sanofi-aventis Canada |
02237925 |
FT04262 |
July 2022 |
June 15, 2021 |
|
IRBESARTAN 150 mg TABLETS |
Pro Doc Ltd. |
02365200 |
617491 |
July 2021 |
May 30, 2021 |
|
IRBESARTAN 150 mg TABLETS |
Pro Doc Ltd. |
02365200 |
618112 |
March 2022 |
May 30, 2021 |
|
IRBESARTAN 150 mg TABLETS |
Pro Doc Ltd. |
02365200 |
624632 |
January 2023 |
May 30, 2021 |
|
IRBESARTAN 150 mg TABLETS |
Pro Doc Ltd. |
02365200 |
624633 |
January 2023 |
May 30, 2021 |
|
IRBESARTAN 150 mg TABLETS |
Pro Doc Ltd. |
02365200 |
630546 |
May 2023 |
May 30, 2021 |
|
IRBESARTAN 300 mg TABLETS |
Pro Doc Ltd. |
02365219 |
615929 |
June 2021 |
May 30, 2021 |
|
IRBESARTAN 300 mg TABLETS |
Pro Doc Ltd. |
02365219 |
617091 |
June 2021 |
May 30, 2021 |
|
IRBESARTAN 300 mg TABLETS |
Pro Doc Ltd. |
02365219 |
617264 |
June 2021 |
May 30, 2021 |
|
IRBESARTAN 300 mg TABLETS |
Pro Doc Ltd. |
02365219 |
620694 |
March 2022 |
May 30, 2021 |
|
IRBESARTAN 300 mg TABLETS |
Pro Doc Ltd. |
02365219 |
624189 |
May 2022 |
May 30, 2021 |
|
IRBESARTAN 300 mg TABLETS |
Pro Doc Ltd. |
02365219 |
624190 |
May 2022 |
May 30, 2021 |
|
IRBESARTAN 300 mg TABLETS |
Pro Doc Ltd. |
02365219 |
624191 |
January 2023 |
May 30, 2021 |
|
IRBESARTAN 300 mg TABLETS |
Pro Doc Ltd. |
02365219 |
624192 |
January 2023 |
May 30, 2021 |
|
IRBESARTAN 75 mg TABLETS |
Pro Doc Ltd. |
02365197 |
616518 |
June 2021 |
May 30, 2021 |
|
IRBESARTAN 75 mg TABLETS |
Pro Doc Ltd. |
02365197 |
619960 |
November 2021 |
May 30, 2021 |
|
IRBESARTAN 75 mg TABLETS |
Pro Doc Ltd. |
02365197 |
622192 |
May 2022 |
May 30, 2021 |
|
IRBESARTAN 75 mg TABLETS |
Pro Doc Ltd. |
02365197 |
622193 |
December 2022 |
May 30, 2021 |
|
IRBESARTAN HCT/TABLET/150/12.5 mg |
Sivem Pharmaceuticals |
02385317 |
JN5054 |
January 2022 |
May 30, 2021 |
|
IRBESARTAN HCT/TABLET/150/12.5 mg |
Sivem Pharmaceuticals |
02385317 |
JV2163 |
April 2022 |
May 30, 2021 |
|
IRBESARTAN HCT/TABLET/150/12.5 mg |
Sivem Pharmaceuticals |
02385317 |
JY7867 |
June 2022 |
May 30, 2021 |
|
IRBESARTAN HCT/TABLET/150/12.5 mg |
Sivem Pharmaceuticals |
02385317 |
KT2519 |
May 2023 |
May 30, 2021 |
|
IRBESARTAN HCT/TABLET/150/12.5 mg |
Sivem Pharmaceuticals |
02385317 |
KT2520 |
May 2023 |
May 30, 2021 |
|
IRBESARTAN HCT/TABLET/300/12.5 mg |
Sivem Pharmaceuticals |
02385325 |
JP2979 |
January 2022 |
May 30, 2021 |
|
IRBESARTAN HCT/TABLET/300/12.5 mg |
Sivem Pharmaceuticals |
02385325 |
JP2980 |
January 2022 |
May 30, 2021 |
|
IRBESARTAN HCT/TABLET/300/12.5 mg |
Sivem Pharmaceuticals |
02385325 |
JU8206 |
April 2022 |
May 30, 2021 |
|
IRBESARTAN HCT/TABLET/300/12.5 mg |
Sivem Pharmaceuticals |
02385325 |
JU8207 |
April 2022 |
May 30, 2021 |
|
IRBESARTAN HCT/TABLET/300/25 mg |
Sivem Pharmaceuticals |
02385333 |
JX8881 |
June 2022 |
May 30, 2021 |
|
IRBESARTAN HCT/TABLET/300/25 mg |
Sivem Pharmaceuticals |
02385333 |
JX8882 |
June 2022 |
May 30, 2021 |
|
IRBESARTAN HCT/TABLET/300/25 mg |
Sivem Pharmaceuticals |
02385333 |
JB0216 |
May 2021 |
May 30, 2021 |
|
IRBESARTAN/TABLET/150 mg |
Sivem Pharmaceuticals |
02385295 |
KC7215 |
July 2021 |
May 30, 2021 |
|
IRBESARTAN/TABLET/300 mg |
Sivem Pharmaceuticals |
02385309 |
KF8325 |
July 2021 |
May 30, 2021 |
|
IRBESARTAN-HCTZ 150/12.5 mg TABLETS |
Pro Doc Ltd. |
02365162 |
JN4976 |
January 2022 |
May 30, 2021 |
|
IRBESARTAN-HCTZ 150/12.5 mg TABLETS |
Pro Doc Ltd. |
02365162 |
JU3231 |
January 2022 |
May 30, 2021 |
|
IRBESARTAN-HCTZ 150/12.5 mg TABLETS |
Pro Doc Ltd. |
02365162 |
JY1913 |
June 2022 |
May 30, 2021 |
|
IRBESARTAN-HCTZ 300/12.5 mg TABLETS |
Pro Doc Ltd. |
02365170 |
HW0586 |
February 2021 |
May 30, 2021 |
|
IRBESARTAN-HCTZ 300/12.5 mg TABLETS |
Pro Doc Ltd. |
02365170 |
HW0587 |
February 2021 |
May 30, 2021 |
|
IRBESARTAN-HCTZ 300/12.5 mg TABLETS |
Pro Doc Ltd. |
02365170 |
JR7823 |
February 2022 |
May 30, 2021 |
|
IRBESARTAN-HCTZ 300/12.5 mg TABLETS |
Pro Doc Ltd. |
02365170 |
JR7824 |
February 2022 |
May 30, 2021 |
|
IRBESARTAN-HCTZ 300/12.5 mg TABLETS |
Pro Doc Ltd. |
02365170 |
JU7506 |
April 2022 |
May 30, 2021 |
|
IRBESARTAN-HCTZ 300/25 mg TABLETS |
Pro Doc Ltd. |
02365189 |
JS0731 |
February 2022 |
May 30, 2021 |
|
MINT- IRBESARTAN /HCTZ 150/12.5 mg TABLETS |
Mint Pharmaceuticals Inc. |
02392992 |
1805011398 |
August 2021 |
May 30, 2021 |
|
MINT- IRBESARTAN /HCTZ 300/12.5 mg TABLETS |
Mint Pharmaceuticals Inc. |
02393018 |
1805011402 |
August 2021 |
May 30, 2021 |
|
MINT- IRBESARTAN /HCTZ 300/25.0 mg TABLETS |
Mint Pharmaceuticals Inc. |
02393026 |
1805011576 |
August 2021 |
May 30, 2021 |
|
pms-IRBESARTAN 150 mg TABLETS |
Pharmascience Inc. |
02317079 |
617492 |
July 2021 |
May 30, 2021 |
|
pms-IRBESARTAN 150 mg TABLETS |
Pharmascience Inc. |
02317079 |
624634 |
January 2023 |
May 30, 2021 |
|
pms-IRBESARTAN 150 mg TABLETS |
Pharmascience Inc. |
02317079 |
630661 |
May 2023 |
May 30, 2021 |
|
pms-IRBESARTAN 75 mg TABLETS |
Pharmascience Inc. |
02317060 |
617466 |
November 2021 |
May 30, 2021 |
|
pms-IRBESARTAN 75 mg TABLETS |
Pharmascience Inc. |
02317060 |
617467 |
November 2021 |
May 30, 2021 |
|
pms-IRBESARTAN 75 mg TABLETS |
Pharmascience Inc. |
02317060 |
617468 |
November 2021 |
May 30, 2021 |
|
pms-IRBESARTAN 75 mg TABLETS |
Pharmascience Inc. |
02317060 |
620272 |
November 2021 |
May 30, 2021 |
|
pms-IRBESARTAN 75 mg TABLETS |
Pharmascience Inc. |
02317060 |
622195 |
December 2022 |
May 30, 2021 |
|
pms-IRBESARTAN 75 mg TABLETS |
Pharmascience Inc. |
02317060 |
624738 |
December 2022 |
May 30, 2021 |
|
pms-IRBESARTAN-HCTZ 300/12.5 mg TABLETS |
Pharmascience Inc. |
02328526 |
621822 |
July 2021 |
May 30, 2021 |
|
pms-IRBESARTAN-HCTZ 300/12.5 mg TABLETS |
Pharmascience Inc. |
02328526 |
621823 |
November 2021 |
May 30, 2021 |
|
pms-IRBESARTAN-HCTZ 300/12.5 mg TABLETS |
Pharmascience Inc. |
02328526 |
625318 |
February 2022 |
May 30, 2021 |
|
pms-IRBESARTAN-HCTZ 300/12.5 mg TABLETS |
Pharmascience Inc. |
02328526 |
625902 |
January 2022 |
May 30, 2021 |
|
pms-IRBESARTAN-HCTZ 300/12.5 mg TABLETS |
Pharmascience Inc. |
02328526 |
629920 |
July 2022 |
May 30, 2021 |
|
pms-IRBESARTAN-HCTZ 300/12.5 mg TABLETS |
Pharmascience Inc. |
02328526 |
631052 |
October 2022 |
May 30, 2021 |
|
pms-IRBESARTAN-HCTZ 300/12.5 mg TABLETS |
Pharmascience Inc. |
02328526 |
632583 |
November 2022 |
May 30, 2021 |
|
pms-IRBESARTAN-HCTZ 300/25 mg TABLETS |
Pharmascience Inc. |
02328534 |
624235 |
June 2021 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 150 mg |
Sun Pharma Canada Inc. |
02406829 |
AB47146 |
April 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 150 mg |
Sun Pharma Canada Inc. |
02406829 |
AB47147 |
April 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 150 mg |
Sun Pharma Canada Inc. |
02406829 |
AB47148 |
April 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 150 mg |
Sun Pharma Canada Inc. |
02406829 |
AB57691 |
May 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 150 mg |
Sun Pharma Canada Inc. |
02406829 |
AB57688 |
May 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 150 mg |
Sun Pharma Canada Inc. |
02406829 |
AB57689 |
May 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 150 mg |
Sun Pharma Canada Inc. |
02406829 |
AB58827 |
May 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 150 mg |
Sun Pharma Canada Inc. |
02406829 |
3990655 |
November 2021 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 300 mg |
Sun Pharma Canada Inc. |
02406837 |
AB47144 |
April 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 300 mg |
Sun Pharma Canada Inc. |
02406837 |
AB47145 |
April 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 300 mg |
Sun Pharma Canada Inc. |
02406837 |
AB58305 |
May 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 300 mg |
Sun Pharma Canada Inc. |
02406837 |
AB58304 |
May 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 300 mg |
Sun Pharma Canada Inc. |
02406837 |
AB58312 |
May 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 300 mg |
Sun Pharma Canada Inc. |
02406837 |
AB58314 |
May 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 300 mg |
Sun Pharma Canada Inc. |
02406837 |
AB58828 |
May 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 300 mg |
Sun Pharma Canada Inc. |
02406837 |
AB57696 |
May 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 300 mg |
Sun Pharma Canada Inc. |
02406837 |
AB70496 |
June 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 300 mg |
Sun Pharma Canada Inc. |
02406837 |
AB70498 |
June 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 300 mg |
Sun Pharma Canada Inc. |
02406837 |
AB70499 |
June 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 300 mg |
Sun Pharma Canada Inc. |
02406837 |
3991358 |
November 2021 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 300 mg |
Sun Pharma Canada Inc. |
02406837 |
3991360 |
November 2021 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 75 mg |
Sun Pharma Canada Inc. |
02406810 |
AB47143 |
April 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 75 mg |
Sun Pharma Canada Inc. |
02406810 |
AB58473 |
May 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 75 mg |
Sun Pharma Canada Inc. |
02406810 |
AB58829 |
May 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 75 mg |
Sun Pharma Canada Inc. |
02406810 |
3994101 |
November 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN 150 mg TABLETS |
Sandoz Canada Inc. |
02328488 |
KC7216 |
July 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN 300 mg TABLETS |
Sandoz Canada Inc. |
02328496 |
KF8326 |
July 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 150/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337428 |
JF5840 |
August 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 150/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337428 |
JN4197 |
January 2022 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 150/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337428 |
JN4971 |
January 2022 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 150/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337428 |
JU3217 |
January 2022 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 150/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337428 |
JV2167 |
April 2022 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 150/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337428 |
JF8892 |
August 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 150/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337428 |
JN4191 |
January 2022 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337436 |
JA4033 |
February 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337436 |
HY7383 |
May 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337436 |
JA4034 |
May 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337436 |
JE2529 |
July 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337436 |
JK7459 |
October 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337436 |
JK7460 |
October 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337436 |
JM3516 |
October 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337436 |
JM3517 |
November 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337436 |
JR7821 |
February 2022 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337436 |
JU7500 |
April 2022 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337436 |
JU7501 |
April 2022 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337436 |
JU7502 |
April 2022 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337436 |
JU7503 |
April 2022 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337436 |
JY0147 |
April 2022 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337436 |
JM4631 |
November 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337436 |
JZ2686 |
April 2022 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/25 mg TABLETS |
Sandoz Canada Inc. |
02337444 |
JB0221 |
May 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/25 mg TABLETS |
Sandoz Canada Inc. |
02337444 |
JB0222 |
May 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/25 mg TABLETS |
Sandoz Canada Inc. |
02337444 |
JC4402 |
June 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/25 mg TABLETS |
Sandoz Canada Inc. |
02337444 |
JC4404 |
June 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/25 mg TABLETS |
Sandoz Canada Inc. |
02337444 |
JH2487 |
June 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/25 mg TABLETS |
Sandoz Canada Inc. |
02337444 |
JR7112 |
January 2022 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/25 mg TABLETS |
Sandoz Canada Inc. |
02337444 |
JR7833 |
January 2022 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/25 mg TABLETS |
Sandoz Canada Inc. |
02337444 |
JU3181 |
February 2022 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/25 mg TABLETS |
Sandoz Canada Inc. |
02337444 |
JW9512 |
May 2022 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/25 mg TABLETS |
Sandoz Canada Inc. |
02337444 |
JW9513 |
May 2022 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/25 mg TABLETS |
Sandoz Canada Inc. |
02337444 |
KC1750 |
August 2022 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/25 mg TABLETS |
Sandoz Canada Inc. |
02337444 |
JE1833 |
June 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/25 mg TABLETS |
Sandoz Canada Inc. |
02337444 |
JR8726 |
January 2022 |
May 30, 2021 |
|
Losartan |
|||||
|
AURO-LOSARTAN 100 mg |
Auro Pharma Inc. |
02403358 |
AEJ1020001A |
19 December 2023 |
October 1, 2021 |
|
AURO-LOSARTAN 100 mg |
Auro Pharma Inc. |
02403358 |
AEJ1020002A |
20 December 2023 |
October 1, 2021 |
|
AURO-LOSARTAN 100 mg |
Auro Pharma Inc. |
02403358 |
AEJ1020003A |
21 December 2023 |
October 1, 2021 |
|
AURO-LOSARTAN 50 mg |
Auro Pharma Inc. |
02403331 |
AEJ5020001A |
16 December 2023 |
October 1, 2021 |
|
AURO-LOSARTAN 50 mg |
Auro Pharma Inc. |
02403331 |
AEJ5020002A |
17 December 2023 |
October 1, 2021 |
|
AURO-LOSARTAN 50 mg |
Auro Pharma Inc. |
02403331 |
AEJ5020003A |
18 December 2023 |
October 1, 2021 |
|
AURO-LOSARTAN 25 mg |
Auro Pharma Inc. |
02403323 |
AEJ2520001A |
19 December 2023 |
October 1, 2021 |
|
AURO-LOSARTAN 100 mg TABLETS |
Auro Pharma Inc. |
02403358 |
WB1019001-A |
14 August 2022 |
May 30, 2021 |
|
AURO-LOSARTAN 100 mg TABLETS |
Auro Pharma Inc. |
02403358 |
WB1019001-B |
14 August 2022 |
May 30, 2021 |
|
AURO-LOSARTAN 25 mg TABLETS |
Auro Pharma Inc. |
02403323 |
WB2519001-A |
14 August 2022 |
May 30, 2021 |
|
AURO-LOSARTAN 50 mg TABLETS |
Auro Pharma Inc. |
02403331 |
WB5019001-A |
14 August 2022 |
May 30, 2021 |
|
AURO-LOSARTAN 50 mg TABLETS |
Auro Pharma Inc. |
02403331 |
WB5019001-B |
14 August 2022 |
May 30, 2021 |
|
LOSARTAN 25 MG TABLETS |
Sanis Health Inc. |
02388863 |
KS3239 |
02/2022 |
September 16, 2021 |
|
LOSARTAN 25 MG TABLETS |
Sanis Health Inc. |
02388863 |
KV8086 |
06/2022 |
September 16, 2021 |
|
LOSARTAN 25 MG TABLETS |
Sanis Health Inc. |
02388863 |
LH0370 |
06/2022 |
September 16, 2021 |
|
LOSARTAN 50 MG TABLETS |
Sanis Health Inc. |
02388871 |
KS1007 |
02/2022 |
September 16, 2021 |
|
LOSARTAN 50 MG TABLETS |
Sanis Health Inc. |
02388871 |
KS8836 |
02/2022 |
September 16, 2021 |
|
LOSARTAN 50 MG TABLETS |
Sanis Health Inc. |
02388871 |
KY7469 |
06/2022 |
September 16, 2021 |
|
LOSARTAN 50 MG TABLETS |
Sanis Health Inc. |
02388871 |
LB2316 |
08/2022 |
September 16, 2021 |
|
LOSARTAN 100 MG TABLETS |
Sanis Health Inc. |
02388898 |
KS9031 |
02/2022 |
September 16, 2021 |
|
LOSARTAN 100 MG TABLETS |
Sanis Health Inc. |
02388898 |
KY5728 |
07/2022 |
September 16, 2021 |
|
LOSARTAN 100 MG TABLETS |
Sanis Health Inc. |
02388898 |
LJ2274 |
08/2022 |
September 16, 2021 |
|
LOSARTAN/HCT 50/12.5MG TABLETS |
Sanis Health Inc. |
02427648 |
KS7557 |
02/2022 |
September 16, 2021 |
|
LOSARTAN/HCT 50/12.5MG TABLETS |
Sanis Health Inc. |
02427648 |
KX6499 |
06/2022 |
September 16, 2021 |
|
LOSARTAN/HCT 50/12.5MG TABLETS |
Sanis Health Inc. |
02427648 |
LB3650 |
08/2022 |
September 16, 2021 |
|
LOSARTAN/HCT 100/12.5MG TABLETS |
Sanis Health Inc. |
02427656 |
KS9114 |
03/2022 |
September 16, 2021 |
|
LOSARTAN/HCT 100/12.5MG TABLETS |
Sanis Health Inc. |
02427656 |
LB1656 |
08/2022 |
September 16, 2021 |
|
LOSARTAN/HCT 100/12.5MG TABLETS |
Sanis Health Inc. |
02427656 |
LG7830 |
08/2022 |
September 16, 2021 |
|
LOSARTAN/HCT 100/25MG TABLETS |
Sanis Health Inc. |
02427664 |
KS3078 |
02/2022 |
September 16, 2021 |
|
LOSARTAN/HCT 100/25MG TABLETS |
Sanis Health Inc. |
02427664 |
KU3077 |
02/2022 |
September 16, 2021 |
|
LOSARTAN/HCT 100/25MG TABLETS |
Sanis Health Inc. |
02427664 |
KZ7521 |
06/2022 |
September 16, 2021 |
|
LOSARTAN /TABLET/25 mg |
Sivem Pharmaceuticals ULC |
02388790 |
0080620 |
June 2023 |
May 30, 2021 |
|
LOSARTAN /TABLET/25 mg |
Sivem Pharmaceuticals ULC |
02388790 |
0090620 |
June 2023 |
May 30, 2021 |
|
LOSARTAN /TABLET/100 mg |
Sivem Pharmaceuticals ULC |
02388812 |
2151119 |
November 2023 |
May 30, 2021 |
|
LOSARTAN/TABLET/100 mg |
Sivem Pharmaceuticals ULC |
02388812 |
2101018 |
October 2021 |
May 30, 2021 |
|
LOSARTAN/TABLET/100 mg |
Sivem Pharmaceuticals ULC |
02388812 |
2020219 |
February 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/100 mg |
Sivem Pharmaceuticals ULC |
02388812 |
2030219 |
February 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/100 mg |
Sivem Pharmaceuticals ULC |
02388812 |
2040219 |
February 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/100 mg |
Sivem Pharmaceuticals ULC |
02388812 |
2090619 |
June 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/100 mg |
Sivem Pharmaceuticals ULC |
02388812 |
2100919 |
September 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/100 mg |
Sivem Pharmaceuticals ULC |
02388812 |
2110919 |
September 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/100 mg |
Sivem Pharmaceuticals ULC |
02388812 |
2120919 |
September 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/100 mg |
Sivem Pharmaceuticals ULC |
02388812 |
2130919 |
September 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/100 mg |
Sivem Pharmaceuticals ULC |
02388812 |
2050420 |
April 2023 |
May 30, 2021 |
|
LOSARTAN/TABLET/100 mg |
Sivem Pharmaceuticals ULC |
02388812 |
2060420 |
April 2023 |
May 30, 2021 |
|
LOSARTAN/TABLET/100 mg |
Sivem Pharmaceuticals ULC |
02388812 |
2070817 |
August 2021 |
May 30, 2021 |
|
LOSARTAN/TABLET/100 mg |
Sivem Pharmaceuticals ULC |
02388812 |
2040218 |
February 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/100 mg |
Sivem Pharmaceuticals ULC |
02388812 |
2140919 |
September 2023 |
May 30, 2021 |
|
LOSARTAN/TABLET/25 mg |
Sivem Pharmaceuticals ULC |
02388790 |
0050919 |
September 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/25 mg |
Sivem Pharmaceuticals ULC |
02388790 |
0060919 |
September 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/25 mg |
Sivem Pharmaceuticals ULC |
02388790 |
0070919 |
September 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/25 mg |
Sivem Pharmaceuticals ULC |
02388790 |
0080919 |
September 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/25 mg |
Sivem Pharmaceuticals ULC |
02388790 |
0080919A |
September 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/25 mg |
Sivem Pharmaceuticals ULC |
02388790 |
0101019 |
October 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/25 mg |
Sivem Pharmaceuticals ULC |
02388790 |
0101019A |
October 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/25 mg |
Sivem Pharmaceuticals ULC |
02388790 |
0030120 |
January 2023 |
May 30, 2021 |
|
LOSARTAN/TABLET/25 mg |
Sivem Pharmaceuticals ULC |
02388790 |
0040120 |
January 2023 |
May 30, 2021 |
|
LOSARTAN/TABLET/50 mg |
Sivem Pharmaceuticals ULC |
02388804 |
1121018 |
October 2021 |
May 30, 2021 |
|
LOSARTAN/TABLET/50 mg |
Sivem Pharmaceuticals ULC |
02388804 |
1131018 |
October 2021 |
May 30, 2021 |
|
LOSARTAN/TABLET/50 mg |
Sivem Pharmaceuticals ULC |
02388804 |
1130819 |
August 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/50 mg |
Sivem Pharmaceuticals ULC |
02388804 |
1140819 |
August 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/50 mg |
Sivem Pharmaceuticals ULC |
02388804 |
1150819 |
August 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/50 mg |
Sivem Pharmaceuticals ULC |
02388804 |
1160819 |
August 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/50 mg |
Sivem Pharmaceuticals ULC |
02388804 |
1180919 |
September 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/50 mg |
Sivem Pharmaceuticals ULC |
02388804 |
1070220 |
February 2023 |
May 30, 2021 |
|
LOSARTAN/TABLET/50 mg |
Sivem Pharmaceuticals ULC |
02388804 |
1080220 |
February 2023 |
May 30, 2021 |
|
LOSARTAN/TABLET/50 mg |
Sivem Pharmaceuticals ULC |
02388804 |
1090220 |
February 2023 |
May 30, 2021 |
|
LOSARTAN/TABLET/50 mg |
Sivem Pharmaceuticals ULC |
02388804 |
1100220 |
February 2023 |
May 30, 2021 |
|
LOSARTAN/TABLET/50 mg |
Sivem Pharmaceuticals ULC |
02388804 |
1110220 |
February 2023 |
May 30, 2021 |
|
LOSARTAN/TABLET/50 mg |
Sivem Pharmaceuticals ULC |
02388804 |
1060220 |
February 2023 |
May 30, 2021 |
|
LOSARTAN/TABLET/50 mg |
Sivem Pharmaceuticals ULC |
02388804 |
1170919 |
September 2023 |
May 30, 2021 |
|
LOSARTAN/TABLET/50 mg |
Sivem Pharmaceuticals ULC |
02388804 |
1120620 |
June 2024 |
May 30, 2021 |
|
LOSARTAN/TABLET/50 mg |
Sivem Pharmaceuticals ULC |
02388804 |
1010419 |
April 2022 |
August 28, 2021 |
|
LOSARTAN/TABLET/50 mg |
Sivem Pharmaceuticals ULC |
02388804 |
1020419 |
April 2022 |
August 28, 2021 |
|
Sandoz LOSARTAN 25 mg TABLETS |
Sandoz Canada Inc. |
02313332 |
KF3703 |
2021-09-30 |
September 16, 2021 |
|
Sandoz LOSARTAN 25 mg TABLETS |
Sandoz Canada Inc. |
02313332 |
KF3704 |
2021-09-30 |
September 16, 2021 |
|
Sandoz LOSARTAN 25 mg TABLETS |
Sandoz Canada Inc. |
02313332 |
KR0055 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN 25 mg TABLETS |
Sandoz Canada Inc. |
02313332 |
KS3238 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN 25 mg TABLETS |
Sandoz Canada Inc. |
02313332 |
KV8085 |
2022-06-30 |
September 16, 2021 |
|
Sandoz LOSARTAN 25 mg TABLETS |
Sandoz Canada Inc. |
02313332 |
KY3612 |
2022-06-30 |
September 16, 2021 |
|
Sandoz LOSARTAN 50 mg TABLETS |
Sandoz Canada Inc. |
02313340 |
KF3629 |
2021-09-30 |
September 16, 2021 |
|
Sandoz LOSARTAN 50 mg TABLETS |
Sandoz Canada Inc. |
02313340 |
KS1008 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN 50 mg TABLETS |
Sandoz Canada Inc. |
02313340 |
KS1009 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN 50 mg TABLETS |
Sandoz Canada Inc. |
02313340 |
KS8837 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN 50 mg TABLETS |
Sandoz Canada Inc. |
02313340 |
KT8356 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN 50 mg TABLETS |
Sandoz Canada Inc. |
02313340 |
KY7473 |
2022-06-30 |
September 16, 2021 |
|
Sandoz LOSARTAN 50 mg TABLETS |
Sandoz Canada Inc |
02313340 |
KS1006 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN 50 mg TABLETS |
Sandoz Canada Inc |
02313340 |
KY7472 |
2022-06-30 |
September 16, 2021 |
|
Sandoz LOSARTAN 100 mg TABLETS |
Sandoz Canada Inc |
02313359 |
KF3630 |
2021-09-30 |
September 16, 2021 |
|
Sandoz LOSARTAN 100 mg TABLETS |
Sandoz Canada Inc |
02313359 |
KR6172 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN 100 mg TABLETS |
Sandoz Canada Inc |
02313359 |
KS7551 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN 100 mg TABLETS |
Sandoz Canada Inc |
02313359 |
LA1962 |
2022-07-31 |
September 16, 2021 |
|
Sandoz LOSARTAN 100 mg TABLETS |
Sandoz Canada Inc |
02313359 |
LD1621 |
2022-08-31 |
September 16, 2021 |
|
Sandoz LOSARTAN 100 mg TABLETS |
Sandoz Canada Inc |
02313359 |
LJ2275 |
2022-08-31 |
September 16, 2021 |
|
Sandoz LOSARTAN 100 mg TABLETS |
Sandoz Canada Inc |
02313359 |
KR6171 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN 100 mg TABLETS |
Sandoz Canada Inc |
02313359 |
LA0665 |
2022-07-31 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 50/12.5 mg TABLETS |
Sandoz Canada Inc |
02313375 |
KF3705 |
2021-09-30 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 50/12.5 mg TABLETS |
Sandoz Canada Inc |
02313375 |
KF3706 |
2021-09-30 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 50/12.5 mg TABLETS |
Sandoz Canada Inc |
02313375 |
KR8908 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 50/12.5 mg TABLETS |
Sandoz Canada Inc |
02313375 |
KS7564 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 50/12.5 mg TABLETS |
Sandoz Canada Inc |
02313375 |
KX6497 |
2022-06-30 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 50/12.5 mg TABLETS |
Sandoz Canada Inc |
02313375 |
LB3649 |
2022-06-30 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 50/12.5 mg TABLETS |
Sandoz Canada Inc |
02313375 |
KR7041 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 50/12.5 mg TABLETS |
Sandoz Canada Inc |
02313375 |
KS5626 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 50/12.5 mg TABLETS |
Sandoz Canada Inc |
02313375 |
KS5627 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 50/12.5 mg TABLETS |
Sandoz Canada Inc |
02313375 |
KX6500 |
2022-06-30 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 100/12.5 mg TABLETS |
Sandoz Canada Inc |
02362449 |
KF3628 |
2021-09-30 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 100/12.5 mg TABLETS |
Sandoz Canada Inc |
02362449 |
KS3893 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 100/12.5 mg TABLETS |
Sandoz Canada Inc |
02362449 |
KT2043 |
2022-03-31 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 100/12.5 mg TABLETS |
Sandoz Canada Inc |
02362449 |
KY9842 |
2022-07-31 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 100/12.5 mg TABLETS |
Sandoz Canada Inc |
02362449 |
LB1657 |
2022-07-31 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 100/12.5 mg TABLETS |
Sandoz Canada Inc |
02362449 |
KF3714 |
2021-09-30 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 100/12.5 mg TABLETS |
Sandoz Canada Inc |
02362449 |
KS3889 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 100/12.5 mg TABLETS |
Sandoz Canada Inc |
02362449 |
KS3890 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 100/12.5 mg TABLETS |
Sandoz Canada Inc |
02362449 |
KT2044 |
2022-03-31 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 100/12.5 mg TABLETS |
Sandoz Canada Inc |
02362449 |
KY9846 |
2022-07-31 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 100/25 mg TABLETS |
Sandoz Canada Inc |
02313383 |
KG4858 |
2021-09-30 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 100/25 mg TABLETS |
Sandoz Canada Inc |
02313383 |
KU3078 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 100/25 mg TABLETS |
Sandoz Canada Inc |
02313383 |
KS3076 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 100/25 mg TABLETS |
Sandoz Canada Inc |
02313383 |
KZ7522 |
2022-06-30 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 100/25 mg TABLETS |
Sandoz Canada Inc |
02313383 |
KG4859 |
2021-09-30 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 100/25 mg TABLETS |
Sandoz Canada Inc |
02313383 |
KS3077 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 100/25 mg TABLETS |
Sandoz Canada Inc |
02313383 |
KZ7520 |
2022-06-30 |
September 16, 2021 |
|
Teva-Losartan 100 mg tablets |
Teva Canada Ltd. |
02357976 |
2050419 |
April 2022 |
August 28, 2021 |
|
Teva-Losartan 50 mg tablets |
Teva Canada Ltd. |
02357968 |
1070917 |
September 2021 |
August 28, 2021 |
|
Teva-Losartan 50 mg tablets |
Teva Canada Ltd. |
02357968 |
1020419 |
April 2022 |
August 28, 2021 |
|
Teva-Losartan 50 mg tablets |
Teva Canada Ltd. |
02357968 |
1030419 |
April 2022 |
August 28, 2021 |
|
Teva-Losartan 25 mg tablets |
Teva Canada Ltd. |
02380838 |
0040917 |
September 2021 |
August 28, 2021 |
|
TEVA-LOSARTAN 100 mg TABLETS |
Teva Canada Ltd. |
02357976 |
2010219 |
February 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 100 mg TABLETS |
Teva Canada Ltd. |
02357976 |
2010420 |
April 2023 |
May 30, 2021 |
|
TEVA-LOSARTAN 100 mg TABLETS |
Teva Canada Ltd. |
02357976 |
2020219 |
February 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 100 mg TABLETS |
Teva Canada Ltd. |
02357976 |
2020420 |
April 2023 |
May 30, 2021 |
|
TEVA-LOSARTAN 100 mg TABLETS |
Teva Canada Ltd. |
02357976 |
2030420 |
April 2023 |
May 30, 2021 |
|
TEVA-LOSARTAN 100 mg TABLETS |
Teva Canada Ltd. |
02357976 |
2040219 |
February 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 100 mg TABLETS |
Teva Canada Ltd. |
02357976 |
2060419 |
April 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 100 mg TABLETS |
Teva Canada Ltd. |
02357976 |
2080619 |
June 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 100 mg TABLETS |
Teva Canada Ltd. |
02357976 |
2080918 |
September 2021 |
May 30, 2021 |
|
TEVA-LOSARTAN 100 mg TABLETS |
Teva Canada Ltd. |
02357976 |
2091018 |
October 2021 |
May 30, 2021 |
|
TEVA-LOSARTAN 100 mg TABLETS |
Teva Canada Ltd. |
02357976 |
2101018 |
October 2021 |
May 30, 2021 |
|
TEVA-LOSARTAN 100 mg TABLETS |
Teva Canada Ltd. |
02357976 |
2161119 |
November 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 100 mg TABLETS |
Teva Canada Ltd. |
02357976 |
2171119 |
November 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 100 mg TABLETS |
Teva Canada Ltd. |
02357976 |
2030218 |
February 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 100 mg TABLETS |
Teva Canada Ltd. |
02357976 |
2070419 |
April 2023 |
May 30, 2021 |
|
TEVA-LOSARTAN 100 mg TABLETS |
Teva Canada Ltd. |
02357976 |
2181119 |
November 2023 |
May 30, 2021 |
|
TEVA-LOSARTAN 100 mg TABLETS |
Teva Canada Ltd. |
02357976 |
2191119 |
November 2023 |
May 30, 2021 |
|
TEVA-LOSARTAN 100 mg TABLETS |
Teva Canada Ltd. |
02357976 |
2140919 |
September 2023 |
May 30, 2021 |
|
TEVA-LOSARTAN 25 mg TABLETS |
Teva Canada Ltd. |
02380838 |
0010219 |
February 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 25 mg TABLETS |
Teva Canada Ltd. |
02380838 |
0020419 |
April 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 25 mg TABLETS |
Teva Canada Ltd. |
02380838 |
0030419 |
April 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 25 mg TABLETS |
Teva Canada Ltd. |
02380838 |
0031018 |
October 2021 |
May 30, 2021 |
|
TEVA-LOSARTAN 25 mg TABLETS |
Teva Canada Ltd. |
02380838 |
0040120 |
January 2023 |
May 30, 2021 |
|
TEVA-LOSARTAN 25 mg TABLETS |
Teva Canada Ltd. |
02380838 |
0040919 |
September 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 25 mg TABLETS |
Teva Canada Ltd. |
02380838 |
0050620 |
June 2023 |
May 30, 2021 |
|
TEVA-LOSARTAN 25 mg TABLETS |
Teva Canada Ltd. |
02380838 |
0050919 |
September 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 25 mg TABLETS |
Teva Canada Ltd. |
02380838 |
0060620 |
June 2023 |
May 30, 2021 |
|
TEVA-LOSARTAN 25 mg TABLETS |
Teva Canada Ltd. |
02380838 |
0070620 |
June 2023 |
May 30, 2021 |
|
TEVA-LOSARTAN 25 mg TABLETS |
Teva Canada Ltd. |
02380838 |
0010120 |
January 2024 |
May 30, 2021 |
|
TEVA-LOSARTAN 25 mg TABLETS |
Teva Canada Ltd. |
02380838 |
0020120 |
January 2024 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1040120 |
January 2023 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1030120 |
January 2023 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1040419 |
April 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1050419 |
April 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1060419 |
April 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1070419 |
April 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1080918 |
September 2021 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1090819 |
August 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1090918 |
September 2021 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1100819 |
August 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1101018 |
October 2021 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1110819 |
August 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1111018 |
October 2021 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1121018 |
October 2021 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1130819 |
August 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1180919 |
September 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1010120 |
January 2024 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1030218 |
February 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1080419 |
April 2023 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1120819 |
August 2023 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1141018 |
October 2022 |
May 30, 2021 |
|
Valsartan |
|||||
|
Sandoz Valsartan 160 mg TABLETS |
Sandoz Canada Inc. |
02356767 |
KT9598 |
March 2023 |
May 30, 2021 |
|
Sandoz Valsartan 320 mg TABLETS |
Sandoz Canada Inc. |
02356775 |
KT8923 |
April 2023 |
May 30, 2021 |
|
Sandoz Valsartan 320 mg TABLETS |
Sandoz Canada Inc. |
02356775 |
KV6185 |
March 2023 |
May 30, 2021 |
|
Sandoz Valsartan 80 mg TABLETS |
Sandoz Canada Inc. |
02356759 |
KT7180 |
March 2023 |
May 30, 2021 |
|
Sandoz Valsartan 80 mg TABLETS |
Sandoz Canada Inc. |
02356759 |
KT9515 |
April 2023 |
May 30, 2021 |
|
VALSARTAN 160 mg TABLETS |
Sanis Health Inc. |
02366967 |
KT9597 |
March 2023 |
May 30, 2021 |
Également disponible en français
SOURCE Health Canada